1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)piperidine-3-carboxylic acid

Catalog No. :
ACTEBC046
CAS No. :
1255664-88-0
Molecular Formula :
C13H21NO6
Molecular Weight :
287.31

IUPAC Name:1-(tert-butoxycarbonyl)-6-(methoxycarbonyl)piperidine-3-carboxylic acid

1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)piperidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$82.00Login to see priceInquiryInquiry
250mg98%$139.00Login to see priceInquiryInquiry
1g98%$374.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butoxycarbonyl)-6-(methoxycarbonyl)piperidine-3-carboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)-6-(methoxycarbonyl)piperidine-3-carboxylic acid
MDL No.MFCD12026416
Molecular FormulaC13H21NO6
Molecular Weight287.31
SMILESCOC(=O)C1CCC(C(=O)O)CN1C(=O)OC(C)(C)C
InChI KeyLGGXKDKHUROZDD-UHFFFAOYSA-N
Synonym1,2,5-Piperidinetricarboxylic acid, 1-(1,1-dimethylethyl) 2-methyl ester;1-tert-butoxycarbonyl-6-methoxycarbonyl-piperidine-3-carboxylic acid
CAS No.1255664-88-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTEBC046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTEBC046 route product structure diagram
    ACTEBC0461255664-88-0
Inquiry

2. ACTEBC046 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEBC046 route product structure diagram
    ACTEBC0461255664-88-0
Inquiry

Comments (0)